시장보고서

상품코드

1571566

면역침강 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Immunoprecipitation Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Type, By End-use (Academic & Research Institutes, Pharma & Biotech Companies, CROs), By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

면역침강 시장 성장과 동향:

Grand View Research, Inc.의 새로운 보고서에 따르면, 세계 면역침강 시장 규모는 2030년까지 11억 달러에 달할 것으로 예상됩니다.

이 시장은 2024년부터 2030년까지 연평균 5.7%의 성장률을 기록할 것으로 예상됩니다. 생명과학 분야의 성장이 시장을 주도할 것으로 보입니다. 면역침강 기술의 기술 발전도 높은 수요의 원인 중 하나입니다.

면역침전법은 항체를 단백질에 결합시켜 용액에서 표적 단백질을 침전시킬 수 있습니다. 이 기술을 통해 다양한 단백질 샘플에서 특정 단백질이나 단백질 복합체를 분리하고 농축할 수 있습니다. 생명과학 산업의 성장은 주로 주요 기업의 R&D 부문에 대한 대규모 투자로 인해 증가하고 있으며, 2016년 머크는 R&D에 약 2억 8,680만 달러를 투자하여 2,000개 이상의 제품 출시를 지원했습니다.

단백질 정제 방법의 새로운 제품 출시가 시장의 급격한 성장을 이끌었습니다. 예를 들어, 2016년 Thermo Fisher Scientific은 면역 침전-질량 분석 기술을 이용한 새로운 항체 검사 및 검증 방법을 발표했습니다. 이는 항체 제조업체, 연구자 및 기타 고객이 단백질 분석에 적합한 항체를 식별할 수 있도록 돕기 위해 개발되었습니다. 항체, 비드, 완충액 등 다양한 키트와 시약이 출시됨에 따라 이 기술의 채택이 크게 증가할 것으로 예상됩니다.

면역침강 시장 보고서 하이라이트

시약 제품 부문은 2023년 매출 점유율 53.9%로 면역침강 시장을 장악했습니다. 시약 부문은 다양한 면역침강 기술에 널리 사용되는 항체가 지배하고 있습니다.
개별 단백질 면역침강 유형은 2023년 28.6%의 매출 점유율로 면역침강 시장을 장악했습니다.
학술 및 연구기관 부문은 2023년 45.1%의 매출 점유율로 면역침강제 시장을 장악했으며, 정부 보조금, 기부금, 민간단체의 R&D 투자 및 자금 지원 증가에 힘입어 성장세를 이어갈 것으로 보입니다.
북미 면역침강 시장은 2023년 36.7%의 매출 점유율로 세계 면역침강 시장을 장악했습니다.

면역침강 시장 점유율, 지역별, 2023년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 상황

주요 시장 진출 기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Thermo Fisher Scientific Inc.
- Abcam Limited
- BioLegend, Inc.
- Bio-Rad Laboratories, Inc.
- GenScript
- Merck KGaA
- Novus Biologicals
- Takara Bio Inc.
- Biologics International Corp

ksm 24.10.31

Immunoprecipitation Market Growth & Trends:

The global immunoprecipitation market size is anticipated to reach USD 1.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.7% from 2024 to 2030. Growth of the life science sector is expected to drive the market. Technological advancements in immunoprecipitation techniques is another factor contributing to high demand.

Immunoprecipitation helps precipitate target protein from a solution by binding an antibody to that protein. This technique allows isolation and concentration of a particular protein or protein complex out of a sample of numerous different proteins. Growth in the life science industry is rising mainly due to significant investments made in the R&D sector by key players. In 2016, Merck invested around USD 286.8 million in R&D, which supported their launch of over 2,000 products.

Introduction of novel products in protein purification methods has led to rapid growth in the market. For instance, in 2016, Thermo Fisher Scientific introduced a new antibody testing and verification methodology by using Immunoprecipitation-Mass Spectrometry technique. This is developed in order to assist antibody manufacturers, researchers, and other customers in identifying a suitable antibody for protein analysis. Availability of varied kits and reagents, such as antibodies, beads, and buffers is expected to increase the adoption of this technique to a great extent.

Immunoprecipitation Market Report Highlights:

The reagents product segment dominated the immunoprecipitation market with a revenue share of 53.9% in 2023. The reagents segment is dominated by antibodies, which are used extensively for various immunoprecipitation techniques.
The individual protein immunoprecipitation type segment dominated the immunoprecipitation market with a revenue share of 28.6% in 2023.
The academic & research institutes segment dominated the immunoprecipitation market with a revenue share of 45.1% in 2023, fueled by increased R&D investments and funding from government grants, donations, and private organizations.
North America immunoprecipitation market dominated the global immunoprecipitation market with a revenue share of 36.7% in 2023.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Immunoprecipitation Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Immunoprecipitation Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Immunoprecipitation Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Immunoprecipitation Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Kits
- 4.3.1. Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Reagents
- 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Antibodies
  - 4.4.2.1. Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Beads
  - 4.4.3.1. Beads Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Others
  - 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunoprecipitation Market: Type Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Immunoprecipitation Market: Type Movement Analysis, 2023 & 2030 (USD Million)
5.3. Individual Protein Immunoprecipitation
- 5.3.1. Individual Protein Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Protein Complex Immunoprecipitation
- 5.4.1. Protein Complex Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Chromatin Immunoprecipitation
- 5.5.1. Chromatin Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Ribonucleoprotein Immunoprecipitation
- 5.6.1. Ribonucleoprotein Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Tagged Proteins Immunoprecipitation
- 5.7.1. Tagged Proteins Immunoprecipitation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunoprecipitation Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Immunoprecipitation Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Academic & Research Institutes
- 6.3.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
- 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Contract Research Organizations
- 6.5.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Immunoprecipitation Market: Regional Estimates & Trend Analysis

7.1. Immunoprecipitation Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
- 7.2.1. North America Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Canada Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Germany Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. France Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Italy Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Spain Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Norway Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
  - 7.4.2.1. China Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
  - 7.4.3.1. Japan Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. India Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Australia
  - 7.4.5.1. Australia Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. South Korea
  - 7.4.6.1. South Korea Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
  - 7.4.7.1. Thailand Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
  - 7.5.3.1. Argentina Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. South Africa Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Saudi Arabia Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
  - 7.6.4.1. UAE Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Kuwait Immunoprecipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Thermo Fisher Scientific Inc.
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/Strategic Initiatives
- 8.4.2. Abcam Limited
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/Strategic Initiatives
- 8.4.3. BioLegend, Inc.
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/Strategic Initiatives
- 8.4.4. Bio-Rad Laboratories, Inc.
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/Strategic Initiatives
- 8.4.5. GenScript
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/Strategic Initiatives
- 8.4.6. Merck KGaA
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/Strategic Initiatives
- 8.4.7. Novus Biologicals
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/Strategic Initiatives
- 8.4.8. Takara Bio Inc.
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/Strategic Initiatives
- 8.4.9. Biologics International Corp
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/Strategic Initiatives

면역침강 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Immunoprecipitation Market Size, Share & Trends Analysis Report By Product (Kits, Reagents), By Type, By End-use (Academic & Research Institutes, Pharma & Biotech Companies, CROs), By Region, And Segment Forecasts, 2024 - 2030

면역침강 시장 성장과 동향:

면역침강 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 면역침강 시장 변수, 동향, 범위

제4장 면역침강 시장 : 제품 추정·동향 분석

제5장 면역침강 시장 : 유형 추정·동향 분석

제6장 면역침강 시장 : 최종 용도 추정·동향 분석

제7장 면역침강 시장 : 지역 추정·동향 분석